Verofylline

CAS No. 66172-75-6

Verofylline( —— )

Catalog No. M34733 CAS No. 66172-75-6

Verofylline (Verofyllinum) is an orally available, long-acting, multiacting, methylxanthine-substituted bronchodilator with inhibitory effects on PDE4 for the treatment of asthma disease research obesity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 222 In Stock
5MG 333 In Stock
10MG 504 In Stock
25MG 790 In Stock
50MG 1086 In Stock
100MG 1431 In Stock
500MG 2871 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Verofylline
  • Note
    Research use only, not for human use.
  • Brief Description
    Verofylline (Verofyllinum) is an orally available, long-acting, multiacting, methylxanthine-substituted bronchodilator with inhibitory effects on PDE4 for the treatment of asthma disease research obesity.
  • Description
    Verofylline (Verofyllinum) is an orally available, long-acting, multiacting, methylxanthine-substituted bronchodilator with inhibitory effects on PDE4 for the treatment of asthma disease research obesity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    66172-75-6
  • Formula Weight
    250.3
  • Molecular Formula
    C12H18N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(CC)C)N1C2=C(C(=O)N(C)C1=O)NC(C)=N2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • HT-0712

    HT-0712 (IPL-455903) is a novel potent, selective PDE4 inhibitor with IC50 of 0.15 uM for PDE4D3.

  • Arofylline

    Arofylline is a PDE4 inhibitor and can be used for asthma studies.

  • Propentofylline

    Propentofylline (Hextol) is a methylxanthine derivative with neuroprotective, antiproliferative, and anti-inflammatory activity and enhanced synaptic adenosine signaling, which may be useful in the study of Alzheimer's disease, vascular dementia, cognitive impairment, dementia, and chronic pain.